热门资讯> 正文

万达制药第二季度盈利预览

2025-07-30 23:04

Vanda Pharmaceuticals (NASDAQ:VNDA) is scheduled to announce Q2 earnings results on Thursday, July 31st, before market open.
The consensus EPS Estimate is -$0.36 and the consensus revenue estimate is $54.77M (+8.5% Y/Y).

More on Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc. (VNDA) Q1 2025 Earnings Call Transcript
Vanda pharmaceuticals outlines $210M-$250M revenue target for 2025 amid product launches
Seeking Alpha’s Quant Rating on Vanda Pharmaceuticals
Historical earnings data for Vanda Pharmaceuticals
Financial information for Vanda Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。